# Lakewood-Amedex Biotherapeutics Inc. (LABT) · Edgar & Edgarette company card

> Figures from the company's own SEC filings.

SEC CIK 2079272 · fiscal year ended — · 0 audited years read · [page](https://www.pops4.com/boards/company/LABT) · [JSON](https://www.pops4.com/boards/company/LABT.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | — |
| Revenue growth, 1 year | — |
| Revenue growth per year | — |
| Operating margin | — |
| Net margin | — |
| Operating cash flow | — |
| Capital spending | — |
| Free cash flow | — |
| Cash | — |
| Long-term debt | — |
| Total assets | — |
| Total equity | — |
| Equity ÷ assets | — |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures


## Edgarette's reading

The filings carry no annual revenue line Edgarette can read (common for banks and insurers, which report income differently). Nothing weighed, nothing guessed.

## Health Watch, last 12 months

- Item 5.02 Director or officer change: 1, latest 2026-04-28 ([filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026048553/0001213900-26-048553-index.htm))

## Recent filings

- 8-K · filed 2026-09-29 · 5.07 Submission of Matters to a Vote of Security Holders · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026104177/0001213900-26-104177-index.htm)
- S-1 · filed 2026-09-18 · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026101512/0001213900-26-101512-index.htm)
- 10-Q · filed 2026-08-14 · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026089380/0001213900-26-089380-index.htm)
- DEF 14A · filed 2026-08-10 · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026087336/0001213900-26-087336-index.htm)
- 8-K · filed 2026-07-15 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026078328/0001213900-26-078328-index.htm)
- 8-K · filed 2026-06-17 · 3.03 Material Modifications to Rights of Security Holders; 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2079272/000121390026069512/0001213900-26-069512-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0002079272.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2079272

## Cite

POPS4, Edgar & Edgarette: Lakewood-Amedex Biotherapeutics Inc. (LABT) company card, from the company's own SEC filings, accessed 2026-11-06, https://www.pops4.com/boards/company/LABT. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.